Equities

Krsnaa Diagnostics Ltd

KRSNAA:NSI

Krsnaa Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)572.25
  • Today's Change-7.70 / -1.33%
  • Shares traded39.71k
  • 1 Year change-2.97%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 10:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Krsnaa Diagnostics Limited is an India-based diagnostic services provider, both in radiology and pathology. The Company is primarily engaged in the business of providing diagnostic services all over India. The Company is providing radiology and pathology services for X-Ray, computed tomography (CT) scan, magnetic resonance imaging (MRI), mammography, tele- reporting services, and all types of blood and urine investigation. Its technology helps health care professionals diagnose and treat medical problems by imaging the interior of the human body. Its lab services offerings encompass a range of investigations from routine tests to specialized ones. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS), among others. The Company offers its services to public and private hospitals, medical colleges, and community health centers.

  • Revenue in INR (TTM)6.20bn
  • Net income in INR568.40m
  • Incorporated2010
  • Employees2.56k
  • Location
    Krsnaa Diagnostics LtdS.No.243,A-Hissa No.6/6 CTS No.4519Near Mayur Trade Centre, ChinchwadPune 411 019IndiaIND
  • Phone+91 2 027350025
  • Websitehttps://krsnaadiagnostics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Max India Ltd1.76bn-563.80m11.44bn19.00--2.32--6.51-13.08-13.0840.74114.050.24432.0345.05---7.87---9.95--66.9165.15-32.22-24.362.43-18.420.0813---12.642.82-443.01------
GPT Healthcare Ltd3.04bn377.89m11.81bn1.90k30.505.4121.183.894.724.7237.9726.630.90447.3612.82--11.2410.1814.7312.9779.3277.9912.4310.330.932610.810.122712.7810.8518.4222.4626.15-5.19--
Krsnaa Diagnostics Ltd6.20bn568.40m18.48bn2.56k32.852.2814.062.9817.4217.42190.03250.790.59534.634.97--5.466.726.688.5977.2482.559.1711.741.374.230.1648--27.2024.25-8.49--14.21--
Indraprastha Medical Corporation Ltd12.45bn1.24bn22.59bn2.95k18.224.7313.771.8113.5213.52135.7652.121.9566.2219.66--19.3912.7425.2117.0457.4957.379.966.731.8237.750.066429.1313.299.5743.8934.2632.3422.98
Artemis Medicare Services Ltd8.79bn491.41m23.89bn1.94k49.295.3326.712.723.543.5463.0232.750.93640.009.20--5.24--6.66------5.594.590.92082.950.4133--19.149.9627.3219.12----
Shalby Ltd9.34bn840.80m27.68bn2.68k33.192.7720.392.967.787.7886.2193.330.64642.407.44--5.784.827.065.5345.9063.928.948.200.98087.780.272719.1216.0115.1024.1921.578.3919.14
Thyrocare Technologies Ltd5.72bn707.70m32.42bn1.65k45.656.1527.825.6713.4113.41108.0899.520.89594.438.89--10.8918.1712.5520.9770.8569.8112.1519.562.5526.830.074383.568.587.269.94-3.638.88-2.09
Yatharth Hospital & Trauma Cre Srvcs Ltd6.70bn1.14bn35.58bn--26.934.0724.755.3115.3915.3991.17101.84----------11.27--13.7380.1478.5017.0812.307.4741.510.0883--28.8845.7874.0695.813.69--
Healthcare Global Enterprises Ltd19.08bn481.40m50.25bn5.50k105.176.0923.302.633.433.43136.1259.290.759621.966.40--1.65-2.262.26-3.0553.4053.782.17-3.500.85681.390.5956--12.8014.3564.03--0.0453--
Jupiter Life Line Hospitals Ltd10.70bn1.77bn77.14bn3.14k41.076.6035.237.2128.6528.65171.06178.300.94369.3920.79--15.58--17.39--82.28--16.51--3.677.430.00--19.83--142.25------
Data as of May 31 2024. Currency figures normalised to Krsnaa Diagnostics Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

8.06%Per cent of shares held by top holders
HolderShares% Held
ICICI Prudential Asset Management Co. Ltd.as of 30 Apr 2024880.17k2.73%
HDFC Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Jun 2023570.46k1.77%
Nomura Asset Management Singapore Ltd.as of 13 Sep 2021423.92k1.31%
Bandhan Asset Management Co. Ltd.as of 30 Apr 2024401.04k1.24%
Aditya Birla Sun Life Insurance Co. Ltd.as of 30 Apr 2024206.98k0.64%
Dimensional Fund Advisors LPas of 09 May 202454.84k0.17%
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 202430.24k0.09%
Dimensional Fund Advisors Ltd.as of 31 Mar 202416.34k0.05%
Invesco Asset Management (India) Pvt Ltd.as of 30 Apr 202410.96k0.03%
SSgA Funds Management, Inc.as of 09 May 20248.34k0.03%
More ▼
Data from 28 Mar 2024 - 30 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.